Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Check-Cap Ltd.

NASDAQ: CHEKHealthcare / Medical Laboratories & Research / Israel
2.80+0.0500+1.82%Vol 9 7951Y Perf -74.07%
Jan 17th, 2019 15:08
BID2.69 ASK2.90
Open2.80 Previous Close2.75
Pre-Market- After-Trading-
 - -%  - -%
Target Price
14.00 
Analyst Rating
Strong Buy 1.00
Potencial %
400.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)4 
Earnings Rating
Buy
Price Range Ratio 52wk %
6.50 
Earnings Date
5th Nov 2018

Today's Price Range

2.762.80

 

52wk Range

1.6219.78

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
21.74%
3 Months
-24.53%
6 Months
-26.12%
1 Year
-74.07%
3 Years
-87.91%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CHEK2.800.05001.82
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.40
Current Ratio
8.70
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
1 449.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
0.20
PB Ratio
0.98
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-2.10
Cash Flow Per Share
-3.10
Price to Tangible Book
0.98
Book Value per Share
2.99
Enterprise Value (in ths.)
-1 895
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-84.10
ROE last 12 Months
94.49
Return on Assets (5Y Avg)
-36.33
ROA last 12 Months
77.29
Return on Capital (5Y Avg)
20.42
ROC last 12 Months
94.49
Return on invested Capital Q
-15.69
Return on invested Capital Y
119.08
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.55-0.509.09
Q02 2018-0.82-0.7014.63
Q01 2018-1.42-1.2611.27
Q04 2017--0.99-
Q03 2017-2.16-1.5627.78
Q02 2017-1.56-2.04-30.77
Q01 2017-1.92-1.920.00
Q04 2016-1.56-1.80-15.38
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.540.00-
12/2018 FY-2.571.15Positive
3/2019 QR-0.59-3.51Negative
12/2019 FY-1.40-3.70Negative
Next Report Date-
Estimated EPS Next Report-0.53
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume9 795
Shares Outstanding (in ths.)1 600
Trades Count22
Dollar Volume25 587
Avg. Volume32 916
Avg. Weekly Volume21 018
Avg. Monthly Volume60 230
Avg. Quarterly Volume70 198

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

76%24%

Bearish Bullish

59%41%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News